Goulart Cássia da Luz, Maldaner Vinícius, Alves Carla Cristina de Araújo, Milani Mauricio, Milani Juliana, Gonçalves da Costa Ana Clara, Alves Marcela Lopes, Borges Robson Fernando, Sobral Claudia Cristina Conde Holanda, Moraes Letícia de Araújo, Coutinho Jean Carlos, Gomes Nádia Oliveira, Tolfo Franzoni Leandro, Ferrari Filipe, Borghi-Silva Audrey, Cahalin Lawrence P, Cipriano Graziella França B, Cipriano Junior Gerson, Stein Ricardo
Health Sciences and Technologies Post Graduate Program, University of Brasilia (UnB), Brasilia, Brazil.
Cardiopulmonary Physiotherapy Laboratory, Physiotherapy Department, Federal University of Sao Carlos, UFSCar, Sao Carlos, Brazil.
Front Cardiovasc Med. 2025 Aug 12;12:1638317. doi: 10.3389/fcvm.2025.1638317. eCollection 2025.
Long COVID, characterized by persistent symptoms after acute infection, poses a major public health challenge. Understanding its long-term effects is crucial, particularly in relation to cardiorespiratory recovery. This study aimed to assess changes in cardiorespiratory fitness (CRF) and pulmonary function (PF) over 12 months following acute COVID-19, addressing a significant gap in current knowledge about the disease's lasting impact.
This prospective cohort study included 29 individuals previously diagnosed with post-acute COVID-19. The baseline data were collected during the acute phase of infection Participants underwent clinical evaluation, cardiopulmonary exercise testing (CPET), spirometry, and maximal inspiratory pressure (MIP) measurement at baseline and again after 12 months.
After one-year, significant improvements were observed across several CPET parameters, including VE/MVV ratio (Cohen's = 0.66), peak oxygen uptake (VOpeak) in both absolute and relative terms (ml/min: = 0.67; and ml/kg/min: = 0.45), oxygen uptake efficiency slope (OUES; = 0.47) and a reduction in VE/VCO slope ( = 0.80). Pulmonary function improved with increases in % predicted forced expiratory volume in 1 s (FEV; = 0.67) and forced vital capacity (FVC; = 0.67). MIP improved significantly ( = 0.67), and the prevalence of inspiratory muscle weakness decreased from 20.7% at baseline to 3.5% at follow-up.
Despite the severity of their initial illness, patients demonstrated substantial recovery in CRF, PF, and inspiratory muscle strength over 12 months.
新冠后综合征以急性感染后持续症状为特征,对公共卫生构成重大挑战。了解其长期影响至关重要,尤其是在心肺恢复方面。本研究旨在评估急性新冠感染后12个月内心肺适能(CRF)和肺功能(PF)的变化,以填补当前关于该疾病长期影响的知识空白。
这项前瞻性队列研究纳入了29名先前被诊断为新冠后综合征的个体。在感染急性期收集基线数据。参与者在基线时以及12个月后再次接受临床评估、心肺运动试验(CPET)、肺活量测定和最大吸气压力(MIP)测量。
一年后,在多个CPET参数上观察到显著改善,包括VE/MVV比值(科恩效应量=0.66)、绝对和相对峰值摄氧量(VOpeak)(ml/min:效应量=0.67;ml/kg/min:效应量=0.45)、摄氧效率斜率(OUES;效应量=0.47)以及VE/VCO斜率降低(效应量=0.80)。肺功能随着1秒用力呼气容积(FEV;效应量=0.67)和用力肺活量(FVC;效应量=0.67)预测值百分比的增加而改善。MIP显著改善(效应量=0.67),吸气肌无力的患病率从基线时的20.7%降至随访时的3.5%。
尽管最初病情严重,但患者在12个月内心肺适能、肺功能和吸气肌力量均有显著恢复。